Open access · Peer reviewed · Open Access Pub
International Journal of Translational Research
Translational research from mechanism to clinical application, with a biological or mechanistic basis.
About the journal
The journal publishes translational research that moves a biological or mechanistic finding toward clinical application. It is written for laboratory scientists, clinical investigators, biomarker and drug-development researchers, and clinicians who apply their findings.
- Full title
- International Journal of Translational Research
- Short title
- IJTR
- Publisher
- Open Access Pub
- Access and license
- Open access under the CC BY 4.0 license; authors retain copyright.
- Peer review
- Single-blind by default; double-blind review is available on request.
- Publication history
- Published since 2017, beginning with Volume 1. Articles are published continuously.
- Fees
- No submission fee. The article processing charge is USD 1,200, payable only after acceptance. Fee-relief requests are considered case by case; contact the editorial office. Withdrawal after submission is subject to the journal's withdrawal policy.
- Contact
- [email protected]
Aims and scope: from mechanism to clinical application
The journal welcomes work at every stage of the pathway below, provided it has a biological or mechanistic basis and a clear route toward clinical application. The stages are illustrative, not exhaustive. Read the full Aims and Scope.
- 1
Mechanism
Molecular, cellular and physiological studies that explain how a disease process works.
- 2
Model
Cell, tissue, animal and computational models that test a mechanism and its modulation.
- 3
Biomarker
Measures of risk, diagnosis, prognosis and response, from discovery through validation in patients.
- 4
Therapeutic
Interventions and clinical studies that carry a mechanistic finding toward patient care.
Article types
The journal accepts seven article types.
- Original Research
- Systematic Review and Meta-Analysis
- Methods and Protocols
- Short Communication
- Data Note
- Commentary
- Case Report (accepted only with a translational component)
From submission to publication
Every manuscript follows the same path. Payment, membership or role does not change how a manuscript is reviewed or decided.
- SubmitThrough ManuscriptZone, with ethics approval and data availability statements where applicable.
- Editorial screeningScope, ethics, completeness and text-overlap screening before review.
- Peer reviewIndependent expert reviewers assess scientific validity and relevance to the field.
- DecisionAccept, revise or decline, based on the editors' assessment of the reviews.
- PublicationAccepted articles are published open access under CC BY 4.0.
Published articles
-
Cancer Stem Cells: A Cause or A Consequence of Field Cancerization
Ninjit Dhanota, Sunil K Arora
- Published
The Editorial Board
View profileEditorial Board
Jian Zou
China
View profileEditorial Board
Liang Chen
China
View profileEditorial Board
Mohammad Parvez Alam
United States
View profileEditorial Board
Natalia Malara
Italy
Submit a manuscript
Authors must use only one submission route for the same manuscript. Before submitting, read the Instructions for Authors and the Editorial Policies.
There are no fixed length limits for any article type; manuscripts should be concise and proportionate to their content.
- Primary routeManuscriptZone
- Alternative routeSimple manuscript submission form
- Assisted routeEditorial office: [email protected]